Trials / Completed
CompletedNCT01935050
Guided Self-Help for Depression in Parkinson's Disease
A Guided Cognitive-Behavioral Self-Help Treatment for Depression in Parkinson's Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Rutgers, The State University of New Jersey · Academic / Other
- Sex
- All
- Age
- 35 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this project is to develop and pilot-test a guided cognitive-behavioral self-help program for mild-to-moderate depression in Parkinson's disease (dPD). We will pilot-test the guided self-help treatment on 20 people with PD and their caregivers. The manual will be revised based on participant feedback. Several feasibility measures regarding the guided self-help program (i.e., recruitment, retention, enjoyment, helpfulness, adherence) will also be assessed. Moreover, preliminary estimates of effect size for this guided self-help program will be calculated and used in future research. We hypothesize that people with PD will report decreases in depression, anxiety, and negative thoughts and improvements in quality life and sleep and that caregivers will report decreases in burden after participating in the guided self-help program
Detailed description
To our knowledge, Cognitive-Behavioral self-help interventions remain unexplored for depression in PD to date. The results of this study will be used to support future treatment development efforts for depression and other psychiatric complications in PD that may improve the access to and quality of mental health care in this medical population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Guided Cognitive-Behavioral Self-Help | Participants will complete the study treatment at home. Bi-weekly telephone support will be provided by study staff. |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2013-09-04
- Last updated
- 2017-12-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01935050. Inclusion in this directory is not an endorsement.